|
|
||||||||
Departments of Pharmacology and Internal Medicine, Division of Nuclear Medicine, University of Michigan Medical School and Veteran's Administration Medical Center, Ann Arbor, Michigan
Correspondence: For reprints contact: Raymond E. Counsell, PhD, Dept. of Pharmacology, M6322 Medical Science Building I, University of Michigan Medical School, Ann Arbor, MI 48109-0626.
ABSTRACT
Rabbits rendered atherosclerotic by mechanical aortic de-endothelialization and 6 wk of cholesterol feeding were administered estradiol-17 ß-cypionate, an anti-atherogenic agent in rabbits. These animals were compared to a similar, untreated group and control animals fed a regular non-atherogenic diet. Iodine-125 cholesteryl iopanoate ([125I]CI), a nonhydrolyzable cholesteryl ester derivative, was administered intravenously at regular intervals throughout the study. Six days after the last dose of [125I]CI, the animals were scanned with a gamma camera. After animals were killed, tissue distribution of the 125I radioactivity showed a significant decrease of [125I]CI accumulation in the aorta of estrogen-treated as compared to untreated, cholesterol-fed animals. However, the accumulation of [125I]CI in the aortas was insufficient to accurately define the presence of atheroma by gamma camera scintigraphy.
This article has been cited by other articles:
![]() |
W. Xiao, T. M. Scott, L. Feng, Z. Yu, L. Wang, J. A. Hughes, and H. Liu Acetylated Low-Density Lipoprotein-Encapsulated Cholesteryl 1,3-Diiopanoate Glyceryl Ether for the Detection of Atherosclerosis in Rabbits J. Nucl. Med., May 1, 2003; 44(5): 770 - 773. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |